title: Preliminary report on reduction of esophagitis by amifostine in patients with non-small-cell lung cancer treated with chemoradiotherapy.
abstract: Esophagitis is a major toxicity of chemoradiotherapy for lung cancer. Twenty-four patients with non-small-cell lung cancer received induction chemotherapy (paclitaxel/carboplatin) followed by concurrent thoracic irradiation (RT) and weekly paclitaxel. Acute esophagitis was scored weekly. Since a high rate of grade 3 esophagitis was noted in the initial group of 12 patients, amifostine (AMI) 500 mg intravenously twice weekly was added to the regimen in the subsequent 12 patients. Esophagitis Index (EI) was calculated as an area under the curve reflecting esophagitis grade over time. Median number of AMI doses was 12 per patient. AMI was well tolerated. Two patients were not evaluable for esophagitis. The incidence of grade 3 esophagitis was 18% in the initial 11 patients versus 9% in the AMI-treated patients (P = not significant). Mean EI was numerically lower in the AMI-treated patients than in the initial group (5.1 vs. 11.6, P = 0.14). The product of RT dose and length of esophagus in the RT field was larger in the AMI group (934 vs. 761, P = 0.035). Median survival time for all patients was 12.4 months. Esophagitis Index, a novel measure of the severity and duration of acute esophagitis, may be reduced in lung cancer patients receiving twice-weekly AMI with thoracic RT and paclitaxel. Twice weekly AMI did not eliminate grade 3 esophagitis; therefore, dose escalation of AMI is planned. The effect of AMI was not due to the shorter irradiated esophageal length. A phase III randomized trial is now open to assess AMI's effect on esophagitis.
authors.affiliation: Kimmel Cancer Center of Jefferson Medical College, Philadelphia, PA, USA. maria.werner-wasik@mail.tju.edu
authors.forename: M
authors.initials: M
authors.lastname: Werner-Wasik
authors.forename: R S
authors.initials: RS
authors.lastname: Axelrod
authors.forename: D P
authors.initials: DP
authors.lastname: Friedland
authors.forename: W
authors.initials: W
authors.lastname: Hauck
authors.forename: L J
authors.initials: LJ
authors.lastname: Rose
authors.forename: A E
authors.initials: AE
authors.lastname: Chapman
authors.forename: S
authors.initials: S
authors.lastname: Grubbs
authors.forename: M
authors.initials: M
authors.lastname: DeShields
authors.forename: W J
authors.initials: WJ
authors.lastname: Curran